Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering. Read press release.

Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management

More than 50% of patients saw treatment changes following Heartflow Plaque Analysis – driving promising LDL cholesterol improvements and individualized care

Discover how you can use Heartflow to advance your approach to coronary artery disease diagnosis, treatment and management.